The pricing of Corbus Pharmaceuticals' share offering is a significant event for the company, as it directly affects its capital structure and shareholder value. While the influx of capital is positive for the company's financial health and future projects, the issuance of additional shares often leads to dilution of existing shareholders' equity. The short-term impact on the stock price could be neutral to slightly negative due to this dilution effect. However, the long-term impact will depend on how effectively the company utilizes the raised capital.